Oxidative Stress, Motor Abilities, and Behavioral Adjustment in Children Treated for Acute Lymphoblastic Leukemia.
Journal Article (Journal Article)
Purpose/objectives
To examine associations among oxidative stress, fine and visual-motor abilities, and behavioral adjustment in children receiving chemotherapy for acute lymphoblastic leukemia (ALL) .Design
A prospective, repeated-measures design .Setting
Two pediatric oncology settings in the southwestern United States.Sample
89 children with ALL were followed from diagnosis to the end of chemotherapy.Methods
Serial cerebrospinal fluid samples were collected during scheduled lumbar punctures and analyzed for oxidative stress biomarkers. Children completed fine motor dexterity, visual processing speed, and visual-motor integration measures at three time points. Parents completed child behavior ratings at the same times.Main research variables
Oxidative stress, fine motor dexterity, visual processing, visual-motor integration, and behavioral adjustment .Findings
Children with ALL had below-average fine motor dexterity, visual processing speed, and visual-motor integration following the induction phase of ALL therapy. By end of therapy, visual processing speed normalized, and fine motor dexterity and visual-motor integration remained below average. Oxidative stress measures correlated with fine motor dexterity and visual-motor integration. Decreased motor functioning was associated with increased hyperactivity and anxiety .Conclusions
Oxidative stress occurs following chemo-therapy for childhood ALL and is related to impaired fine motor skills and visual symptoms .Implications for nursing
Early intervention should be considered to prevent fine motor and visual-spatial deficits, as well as behavioral problems.Full Text
Duke Authors
Cited Authors
- Hockenberry, MJ; Krull, KR; Insel, KC; Harris, LL; Gundy, PM; Adkins, KB; Pasvogel, AE; Taylor, OA; Koerner, KM; Montgomery, DW; Ross, AK; Hill, A; Moore, IM
Published Date
- September 2015
Published In
Volume / Issue
- 42 / 5
Start / End Page
- 542 - 549
PubMed ID
- 26302283
Pubmed Central ID
- PMC4551112
Electronic International Standard Serial Number (EISSN)
- 1538-0688
International Standard Serial Number (ISSN)
- 0190-535X
Digital Object Identifier (DOI)
- 10.1188/15.onf.542-549
Language
- eng